Abstract:Background Muscle wasting is a common complication of chronic kidney disease (CKD) that is associated with higher mortality. Although the mechanisms of myofibre loss in CKD has been widely studied, the contribution of muscle precursor cell (MPC) senescence remains poorly understood. Senescent MPCs no longer proliferate and can produce pro-inflammatory factors or cytokines. In this study, we tested the hypothesis that the senescence associated secretory phenotype (SASP) of MPCs contributes to CKD-induced muscle atrophy and weakness. Methods CKD was induced in mice by 5/6th nephrectomy. Kidney function, muscle size, and function were measured, and markers of atrophy, inflammation, and senescence were evaluated using immunohistochemistry, immunoblots, or qPCR. To study the impact of senescence, a senolytics cocktail of dasatinib + quercetin (D&Q) was given orally to mice for 8 weeks. To investigate CKD-induced senescence at the cellular level, primary MPCs were incubated with serum from CKD or control subjects. The roles of specific proteins in MPC senescence were studied using adenoviral transduction, siRNA, and plasmid transfection. Results In the hindlimb muscles of CKD mice, (i) the senescence biomarker SA-beta-gal was sharply increased (similar to 30-fold); (ii) the DNA damage response marker gamma-H2AX was increased 1.9-fold; and (iii) the senescence pathway markers p21 and p16(INK4a) were increased 1.99-fold and 2.82-fold, respectively (all values, P < 0.05), whereas p53 was unchanged. gamma-H2AX, p21, and p16(INK4A) were negatively correlated at P < 0.05 with gastrocnemius weight, suggesting a causal relationship with muscle atrophy. Administration of the senolytics cocktail to CKD mice for 8 weeks eliminated the disease-related elevation of p21, p16(INK4a), and gamma-H2AX, abolished positive SA-beta-gal, and depressed the high levels of the SASP cytokines, TNF-alpha, IL-6, IL-1 beta, and IFN (all values, P < 0.05). Skeletal muscle weight, myofibre cross-sectional area, and grip function were improved in CKD mice receiving D&Q. Markers of protein degradation, inflammation, and MPCs dysfunction were also attenuated by D&Q treatment compared with the vehicle treatment in 5/6th nephrectomy mice (all values, P < 0.05). Uraemic serum induced senescence in cultured MPCs. Overexpression of FoxO1a in MPCs increased the number of p21(+) senescent cells, and p21 siRNA prevented uraemic serum-induced senescence (P < 0.05). Conclusions Senescent MPCs are likely to contribute to the development of muscle wasting during CKD by producing inflammatory cytokines. Limiting senescence with senolytics ameliorated muscle wasting and improved muscle strength in vivo and restored cultured MPC functions. These results suggest potential new therapeutic targets to improve muscle health and function in CKD.

Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin.

Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age

Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence

Senolytic treatment reverses obesity-mediated senescent cell accumulation in the ovary

ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS

Targeting senescent cells alleviates obesity-induced metabolic dysfunction

Abstract 4138344: High Fat Diet Induced the Premature Senescence of White Adipose Tissue Through Downregulating SIRT1 Expression and Promoting Its S-nitroslyation Modification

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

Senolytics improve physical function and increase lifespan in old age

The Impact of Senescence on Muscle Wasting in Chronic Kidney Disease.

Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer

Legacy Effect of Antioxidant N-acetylcysteine in Cellular Senescence of Diet-induced Obesity Mice

Resveratrol Protects Against High-Fat Diet Induced Renal Pathological Damage and Cell Senescence by Activating SIRT1.

Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis

The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model

Podocytes from hypertensive and obese mice acquire an inflammatory, senescent, and aged phenotype

Senolytic treatment rescues blunted muscle hypertrophy in old mice

Quercetin Alleviates Pulmonary Fibrosis in Mice Exposed to Silica by Inhibiting Macrophage Senescence

Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis

Chronic Hyperinsulinemia Promotes Human Hepatocyte Senescence.